[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100587526":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":30,"responsibleParty":59,"collaborators":62,"id":72,"slug":19,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":77,"eligibilityCriteria":78,"healthyVolunteers":73,"sex":79,"minAge":80,"maxAge":19,"enrollmentInfo":81,"targetDuration":19,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":93,"overallStatus":49,"whyStopped":19,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":112},{"fullName":5,"class":6},"University of Manitoba","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Pharmacogenetic Testing","EXPERIMENTAL","Pharmacogenetic testing panel (CYP2C19, CYP2D6, CYP2B6, CYP3A4, CYP3A5, CYP2C9, CYP4F2, DPYD, HLA-A, HLA-B, NUDT15, SLCO1B1, TPMT, VKORC1, 2C Cluster, UGT1A1)",[13],"Diagnostic Test: Pharmacogenetic Testing",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DIAGNOSTIC_TEST","Participants will donate a 1ml (one-fifth of a teaspoon) sample of saliva. DNA extracted from the saliva sample will be used for genotyping. Genotyping results will be translated into an interpretative clinical report using evidence-based software (Sequence2Script) and delivered to the treating physician for use in their clinical decision-making. The report will contain genotyping results, predicted phenotype, and evidence-based drug selection and dosing recommendations relevant to the patient's current and future care.",[9],null,[21],{"name":22,"affiliation":5,"role":23},"Abdullah Al Maruf, PhD, M.Pharm., B.Pharm","PRINCIPAL_INVESTIGATOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":19,"email":29},"Abdullah Al Maruf, BPharm, MPharm, PhD","CONTACT","204-318-2575","abdullah.maruf@umanitoba.ca",[31,47],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Shared Health Facilities","NOT_YET_RECRUITING","Winnipeg","Manitoba","R3C 3H8","Canada",{"type":39,"coordinates":40},"Point",[41,42],-97.14704,49.8844,{"lat":42,"lon":41},[45],{"name":46,"role":27,"phone":28,"phoneExt":19,"email":29},"Abdullah Al Maruf, PhD, M.Pharm, B.Pharm",{"facility":48,"status":49,"city":34,"state":35,"zip":50,"country":37,"cosmosGeoPoint":51,"geoPoint":53,"contacts":54},"University of Manitoba College of Pharmacy","RECRUITING","R3E 0T5",{"type":39,"coordinates":52},[41,42],{"lat":42,"lon":41},[55,56],{"name":46,"role":27,"phone":28,"phoneExt":19,"email":29},{"name":57,"role":27,"phone":19,"phoneExt":19,"email":58},"Mahin Hasan, MSc, BSc","hasanm33@myumanitoba.ca",{"type":23,"investigatorFullName":60,"investigatorTitle":61,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"Abdullah Al Maruf","Assistant Professor",[63,65,68,70],{"name":64,"class":6},"University of Calgary",{"name":66,"class":67},"Shared Health Manitoba","UNKNOWN",{"name":69,"class":6},"Winnipeg Regional Health Authority",{"name":71,"class":6},"Health Sciences Centre, Winnipeg, Manitoba","100587526",false,"NCT06929533","Pharmacogenomics-Supported Psychotropic Prescribing Trial","Pharmacogenomics-Supported Psychotropic Prescribing Trial (PGx-SUPPORT): A Pilot Implementation Study in Manitoba","PGx-SUPPORT","Inclusion Criteria:\n\n* Aged 18 years or older\n* The initiation, change, dose adjustment, or augmentation of psychotropic medication(s) is indicated\n* The treating clinician thinks PGx testing can benefit and refers the patient to the study\n\nExclusion Criteria:\n\n* Unwillingness to donate saliva samples for genetic analysis\n* History of liver or bone marrow (hematopoietic cell) transplantation\n* PGx testing results are already available\n* No personal health identification number (PHIN) is available","ALL","18 Years",{"count":82,"type":83},200,"ESTIMATED","INTERVENTIONAL",[86],"NA","Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.",[89,90,91,92],"Mental Disorder","Pharmacogenetics","Adverse Drug Reaction (ADR)","Effectiveness",[94,95,96,90,97,98,99,100,101,102],"Adult","Mental Health","Psychiatry","Depression","Anxiety","OCD","Psychosis","Bipolar Disorder","mental illness","2025-09-01",{"date":105,"type":106},"2025-09-08","ACTUAL",{"date":108,"type":106},"2025-07-01",{"date":110,"type":83},"2030-12-31",{"name":5,"class":6},2]